DATATRAK to Attend the 2010 ASCO Annual Meeting
CLEVELAND, May 25 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the Company's attendance at the American Society of Clinical Oncology (ASCO) Annual Meeting to be held at McCormick Place in Chicago, IL June 4th - 8th.
DATATRAK will be exhibiting in the Oncology Professionals Hall on June 5th - 7th in booth 18151. Individuals attending the meeting are encouraged to visit the booth to learn more about DATATRAK ONE™, the Company's unified approach to product and service delivery, and to understand how implementing DATATRAK's oncology-specific solution can lower clinical budgets while improving the quality, safety and efficiency of clinical trials.
About ASCO Annual Meeting.
The 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) will focus on Advancing Quality through Innovation. More than 30,000 cancer specialists from around the world will gather at the meeting to discuss the latest innovations in research, quality, practice and technology in cancer. For more information, please visit http://www.asco.org.
About DATATRAK International, Inc.
DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery in DATATRAK ONE™, the seamless delivery of product and services. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK eClinical™ software solution, deployed worldwide through an ASP or Enterprise Transfer offering, has successfully supported hundreds of international clinical trials involving thousands of clinical research sites and encompassing tens of thousands of patients in 59 countries. DATATRAK has offices located in Cleveland, Ohio, and Bryan, Texas. For more information, visit http://www.datatrak.net.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's quarterly report filed with the Pink OTC Markets on May 12, 2010 announcing its results for the three month period ending March 31, 2010. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.